CYCLOPHARM LIMITED ORDINARY (CYC) Short Interest

Name: CYCLOPHARM LIMITED ORDINARY (CYC) Short Position History
Creator: Shorted
License: https://creativecommons.org/licenses/by/4.0/

CYCLOPHARM LIMITED ORDINARY (ASX:CYC) had 0.00% of shares reported as short positions as of 5 June 2026, representing 6,178 shares. CYCLOPHARM LIMITED ORDINARY operates in the Health Care Equipment & Services industry. Source: ASIC short position report (T+4 delay).

Short interest: 0.00%
Reported positions: 6,178
Industry: Health Care Equipment & Services
As of: 5 June 2026

Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.

CYC

Cyclopharm

Health Care Equipment & Services

Cyclopharm is a global radiopharmaceutical company focused on lung imaging solutions. Their flagship product, Technegas, is used for pulmonary embolism diagnosis and other lung conditions. The company aims to advance nuclear pulmonology imaging through innovation and a commitment to superior patient care.

radiopharmaceuticals

lung imaging

nuclear medicine

pulmonary care

Shorted

short percentage0.00%

reported shorts6.2K

shares on issue126.066M